As the largest, most comprehensive acute leukemia treatment centre in Canada, and a leader in leukemia research and education, the Princess Margaret leukemia program offers people with acute and chronic leukemias and related bone marrow disorders cutting-edge treatment options and access to novel clinical trials.

We offer state-of-the-art, specialized assessment, diagnosis and treatment, and access to clinical trials, for:

  • Acute myeloid leukemia (AML) and related acute leukemias
  • Acute lymphocytic leukemia (ALL) and related acute leukemias
  • Myelodysplastic syndromes (MDS) and related bone marrow disorders
  • Chronic myeloid leukemia (CML)
  • Myeloproliferative neoplasms (MPNs) with a special emphasis on myelofibrosis (MF), but including polycythemia rubra vera (PRV) and essential thrombocythemia (ET)

The Princess Margaret acute leukemia program is staffed by specialized physicians and nurses that deal only with leukemia. Both our physicians and nurses act as consultants to the rest of Ontario and Canada.

Patients at Princess Margaret have access to the most robust leukemia clinical trials and research programs in Canada. At any one time we may run upwards of 20 clinical trials, including investigator-initiated, company-sponsored and cooperative-group-supported Phase I, II and III trials. See also: Leukemia Site Group Research and Clinical Trials »


https://www.uhn.ca/PrincessMargaret/Health_Professionals/Programs_Departments/Breast/Pages/clinical_programs.aspx
https://www.uhn.ca/PrincessMargaret/Education/Continuing_Education_Programs/Pages/continuing_education_programs.aspx
Last reviewed: 1/28/2018
Last modified: 1/4/2019 8:10 AM